Literature DB >> 20002553

Clinical features and outcome of Heterobilharzia americana infection in dogs.

C Fabrick1, A Bugbee, G Fosgate.   

Abstract

BACKGROUND: Heterobilharzia americana (HA), the causative agent of canine schistosomiasis, is a flatworm with a freshwater snail as an intermediate host. Only case reports or small case series evaluating naturally infected dogs have been published.
OBJECTIVE: Describe clinical signs in dogs naturally infected with HA. ANIMALS: Twenty-two dogs naturally infected with HA from 1985 to 2009.
METHODS: Retrospective study. All medical records were searched for HA and schistosomiasis. Only dogs with a diagnosis based on identification of ova on histopathology or fecal saline sedimentation were included.
RESULTS: The median age was 3.1 years (1-12). The median duration of clinical signs before diagnosis was 0.63 months (0.03-12). The most common clinical signs were lethargy (91%), weight loss (77%), hyporexia (68%), vomiting (59%), and diarrhea (55%). Eleven of the 22 dogs were hypercalcemic. Hypercalcemia did not resolve without definitive treatment with praziquantel. HA infection was an incidental diagnosis in 7/22 dogs. Diagnosis was obtained via necropsy (4), histopathology (9), and fecal examination (9). Definitive treatment included praziquantel and fenbendazole. Eighteen dogs were diagnosed antemortem and 17 were treated. Twelve dogs were alive for 6 months to 3 years after diagnosis. CONCLUSIONS AND CLINICAL IMPORTANCE: HA infection occurs in younger, larger breed, indoor dogs. Hypercalcemia does not resolve without praziquantel treatment. Prognosis is good and neither hypercalcemic-induced renal failure nor ascites appears to worsen prognosis. Dogs in affected areas or that have traveled to affected areas that present for weight loss, gastrointestinal or liver disease, and hypercalcemia, should be tested.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20002553     DOI: 10.1111/j.1939-1676.2009.0429.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  3 in total

1.  Efficacy of a low-dose praziquantel and fenbendazole protocol in the treatment of asymptomatic schistosomiasis in dogs.

Authors:  Harry Cridge; Henrique Lupiano; Julia D Nipper; Andrew J Mackin; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2021-05-06       Impact factor: 3.333

2.  ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs.

Authors:  Cynthia R L Webster; Sharon A Center; John M Cullen; Dominique G Penninck; Keith P Richter; David C Twedt; Penny J Watson
Journal:  J Vet Intern Med       Date:  2019-03-07       Impact factor: 3.333

3.  An outbreak of canine schistosomiasis in Utah: Acquisition of a new snail host (Galba humilis) by Heterobilharzia americana, a pathogenic parasite on the move.

Authors:  Eric S Loker; Scott Z Dolginow; Suzanne Pape; Colin D Topper; Pilar Alda; Jean P Pointier; Erika T Ebbs; Melissa C Sanchez; Guilherme G Verocai; Randall J DeJong; Sara V Brant; Martina R Laidemitt
Journal:  One Health       Date:  2021-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.